BIO International Convention 2026

Date: 24th–25th June 2026

Location: Mumbai, India

PharSafer® is pleased to confirm our participation as a Gold Partner at the 6th Edition Drug Safety Symposium India 2026 (DSS India), one of the region’s leading events dedicated to modern pharmacovigilance, patient safety, regulatory strategy, and drug safety operations.

Bringing together senior pharmacovigilance, regulatory, quality, and clinical leaders from across the pharmaceutical industry, DSS India provides an important platform for discussing the evolving operational and compliance challenges shaping global patient safety today.

Exclusive Speaker Session

Join Dr. Graeme Ladds, CEO of PharSafer®, for a thought-provoking session:

“Patient Safety Under Pressure – Are We Still Waiting for the Balloon to Pop?”

Modern pharmacovigilance was built on the lessons learned from some of the industry’s biggest patient safety failures. Since then, regulation, oversight, and safety systems have evolved dramatically – but so has the complexity surrounding them.

Today’s PV environments are under constant pressure from growing case volumes, fragmented global processes, increasing regulatory expectations, outsourcing models, and rising operational burden. More data does not always mean better oversight – and in many organisations, the pressure points are becoming harder to ignore.

This session will explore whether modern pharmacovigilance is genuinely reducing risk, or whether new operational pressures are quietly building beneath the surface. Discussions will cover the realities affecting today’s safety teams, including aggregate reporting, data consistency, medical interpretation, inspection readiness, and the evolving role of automation and AI within patient safety operations.

Using the concept of a “balloon under pressure”, the session will challenge whether current pharmacovigilance models are truly sustainable long term – or simply delaying the next burst.

Meet the PharSafer Team in Mumbai

Our team will be available throughout DSS India 2026 to discuss the growing operational pressures facing modern pharmacovigilance environments and how organisations can build more scalable, sustainable, and inspection-ready safety operations.

Areas of discussion include:

• Clinical & Post-Marketing Pharmacovigilance
• Aggregate Reporting & Medical Review
• Global Regulatory Strategy & Compliance
• Inspection Readiness & Quality Oversight
• Operational Scalability & Outsourcing Models
• Pharmacovigilance Automation & Workflow Optimisation
• RAPTAR® Safety Automation Solutions

Why Meet with PharSafer?

As a global CRO specialising in pharmacovigilance, regulatory strategy, medical services, and safety technology, PharSafer supports organisations across the full product lifecycle – from early clinical development through to post-marketing surveillance.

With increasing operational complexity across modern safety environments, our focus remains on helping organisations improve consistency, strengthen oversight, reduce operational burden, and maintain sustainable compliance without compromising patient safety.

Schedule a Meeting

If you are attending DSS India 2026 and would like to discuss your organisation’s pharmacovigilance challenges, operational goals, or regulatory strategy, we welcome the opportunity to connect with you in Mumbai.

To arrange a meeting with the PharSafer team, please contact us directly or schedule your meeting with us in advance.

We look forward to meeting you at DSS India 2026.